Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive

Alessandro Federico1, Silvia Zappavigna, Marcello Dallio

  • 1Department of Clinical and Experimental Medicine, Second University of Naples, Via Pansini 5 80131 Naples, Italy. Select country.

Insights

Urotensin II and its receptor regulate cancer cell growth and invasion. This axis shows potential as a prognostic marker and therapeutic target in various human cancers.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Urotensin II and its receptor are key regulators of vasoconstriction, impacting blood pressure-related diseases like hypertension.
  • Emerging research implicates Urotensin II and its receptor in metabolic syndrome, diabetes, and schizophrenia.
  • Recent evidence strongly suggests a role for Urotensin II and its receptor in the initiation and progression of epithelial cancers.

Purpose of the Study:

  • To investigate the role of the Urotensin II and Urotensin-II receptor axis in the development and progression of human epithelial cancers.
  • To explore the axis's influence on cancer cell behavior, including growth, motility, and invasion.
  • To assess the potential of Urotensin II and its receptor as prognostic markers in cancer.

Main Methods:

  • Analysis of Urotensin II and Urotensin-II receptor expression and function in various human cancer cell lines (breast, bladder, prostate, colorectal, glioblastoma).
  • Investigation of the axis's regulation of key signaling molecules, including focal adhesion kinase and small Guanosine-5'-triphosphate binding proteins.
  • Correlation of Urotensin II and Urotensin-II receptor expression in tumor tissues with patient clinical outcomes.

Main Results:

  • The Urotensin II and Urotensin-II receptor axis was found to regulate cell growth, motility, and invasion in multiple human cancer types.
  • The axis influences signaling pathways involving focal adhesion kinase and small Guanosine-5'-triphosphate binding proteins, contributing to cancer cell motility and invasion.
  • Tumor expression levels of Urotensin II and its receptor are variably associated with patient prognosis, suggesting their utility as predictive markers.

Conclusions:

  • The Urotensin II and Urotensin-II receptor axis plays a significant role in the pathogenesis of human epithelial cancers.
  • This axis presents a promising novel therapeutic target for cancer treatment.
  • Urotensin II and its receptor represent potential molecular markers for predicting cancer patient outcomes.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K